Alan Bash
Fortuna: 158 992 $ al 31/07/2026
Fortuna: 158 992 $ al 31/07/2026
Alan S.
Bash is Chief Executive Officer at Legend Biotech Corp.
starting in 2026.
Former roles include President, Chief Executive Officer & Director at Checkmate Pharmaceuticals, Inc. in 2022; Chief Executive Officer & Director at ZielBio, Inc. from 2022 to 2024; and Senior Vice President-Commercial Model Innovation at Bristol Myers Squibb Co. Education includes undergraduate studies at Georgetown University and an MBA from Columbia Business School.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
LEGEND BIOTECH CORP. 0,01 % | 14/08/2026 | 17.142 ( 0,01 % ) | 158 992 $ | 31/07/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| LEGEND BIOTECH CORPORATION | Director Ejecutivo | 24/07/2026 |
| Empresas | Cargo | Fin |
|---|---|---|
ZielBio, Inc.
ZielBio, Inc. Medical SpecialtiesHealth Technology Develops a technology for identification of cancerous diseases | Director Ejecutivo | 01/10/2024 |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | - |
| CHECKMATE PHARMACEUTICALS, INC. | Director Ejecutivo | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 6 |
|---|---|
Bristol Myers Squibb Co.
Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
ZielBio, Inc.
ZielBio, Inc. Medical SpecialtiesHealth Technology Develops a technology for identification of cancerous diseases | Health Technology |
Georgetown University
Georgetown University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Columbia Business School
Columbia Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Checkmate Pharmaceuticals, Inc.
Checkmate Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a clinical stage biotechnology company that develop anti-cancer therapeutics | Health Technology |
Legend Biotech Corp.
Legend Biotech Corp. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biopharmaceutical company which engages in the discovery and development of novel cell therapies for oncology | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.